CIK 0001818331
- Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 851966622
- Phone
- +1 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +717 | 31,553 | ||
| 2024-06-01 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −717 | 6,456 | ||
| 2024-05-29 | Casdin Capital, LLC Director | Purchase | +40,000 | $21.07 | $843K | 2,963,509 |
| 2024-05-28 | Casdin Capital, LLC Director | Purchase | +18,304 | $20.61 | $377K | 2,923,509 |
| 2024-05-24 | Casdin Capital, LLC Director | Purchase | +144,196 | $20.12 | $2.9M | 2,905,205 |
| 2024-05-23 | Casdin Capital, LLC Director | Purchase | +7,500 | $19.59 | $147K | 2,761,009 |
| 2024-05-13 | Casdin Capital, LLC Director | Purchase | +50,000 | $23.31 | $1.2M | 2,753,509 |
| 2024-05-02 | PFENNIGER RICHARD C JR Director | Option exercise | +918 | 21,836 | ||
| 2024-05-02 | PFENNIGER RICHARD C JR Director | Option exercise · Restricted Stock Unit | −918 | 918 | ||
| 2024-04-29 | Stueland Katherine Chief Executive Officer | Option exercise | +15,496 | 82,194 | ||
| 2024-04-29 | Stueland Katherine Chief Executive Officer | Sale | −6,325 | $11.04 | $70K | 75,869 |
| 2024-04-29 | Stueland Katherine Chief Executive Officer | Option exercise · Restricted Stock Unit | −15,496 | 30,992 | ||
| 2024-04-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise | +3,013 | 31,940 | ||
| 2024-04-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −1,104 | $11.04 | $12K | 30,836 |
| 2024-04-29 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −3,013 | 6,026 | ||
| 2024-03-26 | Stueland Katherine Chief Executive Officer | Grant or award · Restricted Stock Unit | +320,000 | 320,000 | ||
| 2024-03-26 | Feeley Kevin CHIEF FINANCIAL OFFICER | Grant or award · Restricted Stock Unit | +65,000 | 65,000 | ||
| 2024-03-18 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −8,559 | $10.59 | $91K | 66,698 |
| 2024-03-18 | Saad Kareem CHIEF TRANSFORMATION OFFICER | Sale | −2,008 | $10.59 | $21K | 29,517 |
| 2024-03-18 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −3,253 | $10.59 | $34K | 28,927 |
Page 30 of 36 · 718 trades